MET and metabolic dysfunction-associated steatotic liver disease: The findings of this study align closely with existing NAFLD research, bolstering the notion that chimeric FGF21/HGFR holds promise in improving liver regeneration function in NAFLD-afflicted AML12 cells [23,24,25,26].